Výsledky vyhledávání - "Arletty Hernández"

Akademický článek

Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin‐Resistant Rats: Acute Treatment Versus Long‐Term Protection as an Idiotypic Vaccine for Atherosclerosis

Autor: Yosdel Soto, Arletty Hernández, Roger Sarduy, Victor Brito, Sylvie Marleau, Donna F. Vine, Ana M. Vázquez, Spencer D. Proctor

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 13 (2024)

BACKGROUND Atherosclerosis is triggered by the retention of apolipoprotein B‐containing lipoproteins by proteoglycans. In addition to low‐density lipoprotein, remnant lipoproteins have emerged as pivotal contributors to this pathology, particular

Externí odkaz: https://doaj.org/article/147a6c64e1db4b59a226b05fff62ba7e

Zobrazit plný text záznamu

Ganglioside containing nano-proteoliposome dampens myeloid-derived suppressor cells function and ability to cross-present tumor antigens: a new approach to recover CTL function on tumor bearing individuals

Autor: Circe Mesa, Maura Rabade-Chediak, Liliana Oliver, Luis E. Fernández, Audry Fernández, Leslie Pérez, Rydell Alvarez, Arletty Hernández

Publikováno v: Journal for Immunotherapy of Cancer

Meeting abstracts A perturbation of normal myelopoiesis, as a consequence of tumor growth and development; leads to the proliferation and accumulation of myeloid derived suppressor cells (MDSC), which impair T-cell functions reinforcing tolerance to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a60aad6fe82e3eab2b130c3e08bd5c3
http://europepmc.org/articles/PMC3991200

Zobrazit plný text záznamu

Very small size proteoliposomes abrogate cross-presentation of tumor antigens by myeloid-derived suppressor cells and induce their differentiation to dendritic cells

Autor: Audry Fernández, Rydell Alvarez, Liliana Oliver, Arletty Hernández, Judith Raymond, Circe Mesa, Luis E. Fernández

Publikováno v: Journal for Immunotherapy of Cancer

Background Myeloid-derived suppressor cells (MDSCs) are among the major obstacles that adjuvants for cancer vaccines have to overcome. These cells cross-present tumor-associated antigens (TAA) to naive T lymphocytes with a tolerogenic outcome. Very S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc8a1bf3f4d94cfc817746a31a7116e

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání